Surgical Sealants
General surgical sealing and hemostasis
Key Facts
About OptMed
OptMed is a private medical device company founded in 2005 and headquartered in Irvine, California, focusing on revolutionizing tissue adhesion and protection. Its core innovation is an industry-first methylidene malonate (MM) platform, which enables the creation of biocompatible, high-strength, and flexible medical adhesives and sealants. The company's initial target markets are ophthalmology (e.g., corneal shields, wound closure) and advanced wound care, addressing significant unmet needs for alternatives to sutures and traditional dressings. As a private entity, OptMed likely relies on venture funding and partnerships to advance its technology through development and regulatory pathways toward commercialization.
View full company profile